Nightly News   |  May 26, 2013

FDA gives thumbs down to popular asthma drugs

Dec. 11: The FDA Thursday recommended that two long-acting asthma drugs, Foradil and Serevent, be taken off the market, but suggested that Advair and Symbicort could continue to be sold by prescription. NBC's Robert Bazell reports.

Share This:

Sorry, we do not have a transcript available for this video at this time.